The impact of epithelial ovarian cancer diagnosis on women’s life: a qualitative study

Purpose of investigation: To describe the experience of ovarian cancer patients from symptoms complained before diagnosis until the impact of ovarian cancer diagnosis perceived by women. Materials and Methods: The authors used the Psychological General Well being Index (PGWBI) and a semi-structured interview to measure the overall well being of 39 women diagnosed with ovarian cancer in the period 2005- 2010 at a secondary care hospital in northern Italy. Results: The PGWBI showed that the majority of the women reported general stress. On the semi-structured interview, 95% of women reported having symptoms and 69% reported a stressful event prior to diagnosis. More than 50% of women reported changes concerning life course. Almost all reported that their primary concerns had to do with the surgical scar, weight gain, and hair loss. Conclusions: Ovarian cancer diagnosis has a very stressful effect on the quality of life. Early assessment of psychological problems must be an integral part of the therapeutic pathway. Gynaecologists must provide clear and useful information regarding the disease itself as well as regarding correlated symptom relief.

Ovarian cancer; Survival; Quality of life; Patterns of care.

[1] Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M.: “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. Int. J. Cancer, 2010, 127, 2893.

[2] Bray F., Loos A.H., Tognazzo S., La V.C.: “Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries”. Int. J. Cancer, 2005, 113, 977.

[3] Ferlay J., Parkin D.M., Steliarova- Foucher E.: “Estimates of cancer incidence and mortality in Europe in 2008”. Eur. J. Cancer, 2010, 46, 76.

[4] Mandato V.D., Abrate M., De Iaco P., Pirillo D., Ciarlini G., Leoni M., et al.: “Gynecological Oncology Network of Emilia Romagna Region: Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management”. J. Ovarian. Res., 2013, 6, 19.

[5] Heintz A.P., Odicino F., Maisonneuve P., Quinn M.A., Benedet J.L., Creasman W.T., et al.: “Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynaecological cancer”. Int. J. Gy-naecol. Obstet., 2006, 95, 161.

[6] Oberaigner W., Minicozzi P., Bielska-Lasota M., Allemani C., de Angelis R., Mangone L., Sant M.: “Eurocare Working Group: Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade”. Acta Oncol. 2012, 51, 441.

[7] AIRTUM Working Group: “I tumori in Italia, rapporto 2011: la sopravvivenza dei pazienti oncologici in Italia”. Epidemiol. Prev., 2011, 35, 200.

[8] Grossi E., Mosconi P., Groth N., Niero M., Apolone G.:: “Questionario Psychological Well-Being Index”. Versione italiana. Istituto di Ricerche Farmacologiche “Mario Negri”. Milano: Bracco Imaging SpA., 2002.

[9] Gupta D., Grutsch J.F., Lis C.G.: “Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting”. J. Soc. Integr. Oncol., 2008, 6, 98.

[10] Lorusso D., Mainenti S., Ferrandina G., Scambia G.: “Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials”. Expert. Rev. Anticancer Ther., 2010, 10, 987.

[11] von Gruenigen V.E., Huang H.Q., Gil K.M., Frasure H.E., Armstrong D.K., Wenzel L.B.: “The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study”. Gynecol. Oncol., 2012, 124, 379.

[12] Kornblith A.B., Thaler H.T., Wong G., Vlamis V., Lepore J.M., Loseth D.B., et al.: “Quality of life of women with ovarian cancer”. Gynecol. Oncol., 1995, 59, 231.

[13] Lakusta C.M., Atkinson M.J., Robinson J.W., Nation J., Taenzer P.A., Campo M.G.: “Quality of life in ovarian cancer patients receiving chemotherapy”. Gynecol. Oncol., 2001, 81, 490.

[14] McCorkle R., Pasacreta J., Tang S.T.: “The silent killer: psychological issues in ovarian cancer”. Holist. Nurs. Pract., 2003, 17, 300.

[15] Lowe T., Ferrell B., Leong L.: “Quality-of-life issues in the management of epithelial ovarian cancer”. Curr. Treat. Options Oncol., 2007, 8, 402.

[16] Hamilton A.B.: “Psychological aspects of ovarian cancer”. Cancer Invest., 1999, 17, 335.

[17] Ersek M., Ferrell B.R., Dow K.H., Melancon C.H.: “Quality of life in women with ovarian cancer”. West. J. Nurs. Res., 1997, 19, 334.

[18] Penson R., Cella D., Wenzel L.: “Quality of life in ovarian cancer”. J. Reprod. Med., 2005, 50, 407.

[19] Ferrell B., Cullinane C.A., Ervine K., Melancon C., Uman G.C., Juarez G.: “Perspectives on the impact of ovarian cancer: women’s views of quality of life”. Oncol. Nurs. Forum, 2005, 32, 1143.

[20] Grzankowski K.S., Carney M.: “Quality of life in ovarian cancer”. Cancer Control, 2011, 18, 52.

[21] Ferrell B., Smith S.L., Cullinane C.A., Melancon C.: “Psychological well being and quality of life in ovarian cancer survivors”. Cancer, 2003, 98, 1061.

[22] Fitch M., Gray R.E., Franssen E.: “Perspectives on living with ovarian cancer: young women’s views”. Can. Oncol. Nurs. J., 2000, 10, 101.

[23] Sun C.C., Ramirez P.T., Bodurka D.C.: !Quality of life for patients with epithelial ovarian cancer”. Nat. Clin. Pract. Oncol., 2007, 4, 18.

[24] Arden-Close E., Gidron Y., Moss-Morris R.: “Psychological distress and its correlates in ovarian cancer: a systematic review”. Psychooncology, 2008, 17, 1061.

[25] Koensgen D., Oskay-Oezcelik G., Katsares I., Walle U., Klapp C., Mustea A., et al.: “Nord-Ostdeutschen Gesellschaft für Gynäkologische Onkologie (NOGGO) working group “Quality of life”: Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II study”. Support Care Cancer, 2010, 18, 931.

[26] Power J., Brown L., Ritvo P.: “A qualitative study examining psychosocial distress, coping, and social support across the stages and phases of epithelial ovarian cancer”. Health Care Women Int., 2008, 29, 366.

[27] Beesley V.L., Price M.A., Butow P.N., Green A.C., Olsen C.M.: “Australian Ovarian Cancer Study Group; Australian Ovarian Cancer Study - Quality of Life Study Investigators, Webb PM: Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life”. Psychooncology, 2011, 20, 1161.

[28] Frost M.H., Johnson M.E., Atherton P.J., Petersen W.O., Dose A.M., Kasner M.J., et al.: “Spiritual well- being and quality of life of women with ovarian cancer and their spouses”. J. Support. Oncol., 10, 72. Erratum in: J. Support Oncol., 2012, 10, 131.

[29] Meraner V., Gamper E.M., Grahmann A., Giesinger J.M., Wiesbauer P., Sztankay M., et al.: “Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy”. BMC Cancer, 2012, 12, 77.

[30] Lutgendorf S.K., De Geest K., Bender D., Ahmed A., Goodheart M. J., Dahmoush L., et al.: “Social influences on clinical outcomes of patients with ovarian cancer”. J. Clin. Oncol., 2012, 30, 2885.